DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population

被引:84
作者
Hu, ZB
Wang, YG
Wang, XR
Liang, G
Miao, XP
Xu, YC
Tan, W
Wei, QY
Lin, DX
Shen, HB
机构
[1] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 210029, Peoples R China
[2] Chinese Acad Med Sci, Inst Canc, Dept Etiol & Carcinogenesis, Beijing 100037, Peoples R China
[3] Peking Union Med Coll, Beijing, Peoples R China
[4] Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA
关键词
XPC; polymorphisms; haplotypes; lung cancer; molecular epidemiology;
D O I
10.1002/ijc.20911
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DNA repair is central to normal cellular functions, and polymorphisms of DNA repair genes may cause variation in DNA repair capacity in the general population. Newly identified polymorphisms of xeroderma pigmentosum group C (XPC), one of the nuelcotide excision repair genes, were shown to contribute to genetic susceptibility to cancer. In this study, we hypothesized that 2 exonic variants C499T and A939C and their haplotypes in XPC are associated with lung cancer risk. To test this hypothesis, we performed a case-control study of 320 histologically confirmed lung cancer patients and 322 age and sex frequency -matched cancer-free controls in a Chinese population. Multivariate logistic regression analyses revealed that the risks [adjusted odds ratios (ORs) and 95% confidence intervals (CIs)] associated with the XPC variant genotypes were 1.57 (95% CI = 1.13-2.19) for 499CT/TT and 1.21 (95% CI = 0.87-1.69) for 939AC/CC compared with the 499CC and 939AA wild-type homozygotes, respectively. Individuals with both putative risk genotypes (499CT/TT and 939AC/CC) had a greater risk of lung cancer (adjusted OR = 2.37; 95% CI = 1.33-4.21) compared with individuals with both wild-type genotypes (499CC and 939AA). When we performed the haplotype analysis and assumed the XPC 499T and 939C as ri alleles, the adjusted ORs increased as the number of variants in the haplotype genotypes increased (P-trend < 0.001). In the stratified analysis, the greatest risk was found in smokers having the combined variant genotypes (adjusted OR = 7.36; 95% CI = 3.1917.00) compared with nonsmokers having both wild-type genotypes and in smokers with 2 or 3 haplotype variants (adjusted OR = 7.27; 95% CI = 3.37-15.68) compared with nonsmokers having 0 haplotype variant. These findings indicate that XPC exonic variants may contribute to the risk of lung cancer in the Chinese population, and these variant genotypes may modulate the risk of lung cancer associated with smoking. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:478 / 483
页数:6
相关论文
共 26 条
  • [1] Xeroderma pigmentosum and related disorders: Defects in DNA repair and transcription
    Berneburg, M
    Lehmann, AR
    [J]. ADVANCES IN GENETICS, VOL 43, 2001, 43 : 71 - 102
  • [2] Corrao MA, 2000, B WORLD HEALTH ORGAN, V78, P884
  • [3] Försti A, 2004, ONCOL REP, V11, P917
  • [4] *IARC, 2003, TOB SMOK INV SMOK
  • [5] PIRA PCR designer for restriction analysis of single nucleotide polymorphisms
    Ke, XY
    Collins, A
    Ye, S
    [J]. BIOINFORMATICS, 2001, 17 (09) : 838 - 839
  • [6] A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism
    Khan, SG
    Metter, EJ
    Tarone, RE
    Bohr, VA
    Grossman, L
    Hedayati, M
    Bale, SJ
    Emmert, S
    Kraemer, KH
    [J]. CARCINOGENESIS, 2000, 21 (10) : 1821 - 1825
  • [7] EXPRESSION CLONING OF A HUMAN DNA-REPAIR GENE INVOLVED IN XERODERMA-PIGMENTOSUM GROUP-C
    LEGERSKI, R
    PETERSON, C
    [J]. NATURE, 1992, 359 (6390) : 70 - 73
  • [8] Quality control by DNA repair
    Lindahl, T
    Wood, RD
    [J]. SCIENCE, 1999, 286 (5446) : 1897 - 1905
  • [9] Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms
    Niu, TH
    Qin, ZHS
    Xu, XP
    Liu, JS
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (01) : 157 - 169
  • [10] AT LEAST ONE IN 7 CASES OF CANCER IS CAUSED BY SMOKING - GLOBAL ESTIMATES FOR 1985
    PARKIN, DM
    PISANI, P
    LOPEZ, AD
    MASUYER, E
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (04) : 494 - 504